VVOS

Vivos Therapeutics Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Vivos Therapeutics Inc Stock Price

Vitals

Today's Low:
$0.6800
Today's High:
$0.7299
Open Price:
$0.6800
52W Low:
$0.6
52W High:
$4.14
Prev. Close:
$0.6800
Volume:
13193

Company Statistics

Market Cap.:
$0.016 billion
Book Value:
0.906
Revenue TTM:
$0.017 billion
Operating Margin TTM:
-135.5%
Gross Profit TTM:
$0.013 billion
Gross Profit TTM:
$0.013 billion
Profit Margin:
-132.6%
Return on Assets TTM:
-55.5%
Return on Equity TTM:
-127.3%

Company Profile

Vivos Therapeutics Inc had its IPO on 2020-12-11 under the ticker symbol VVOS.

The company operates in the LIFE SCIENCES sector and SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry. Vivos Therapeutics Inc has a staff strength of 0 employees.

Stock update

Shares of Vivos Therapeutics Inc opened at $0.68 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.68 - $0.73, and closed at $0.69.

This is a +1.47% increase from the previous day's closing price.

A total volume of 13,193 shares were traded at the close of the day’s session.

In the last one week, shares of Vivos Therapeutics Inc have slipped by -31%.

Vivos Therapeutics Inc's Key Ratios

Vivos Therapeutics Inc has a market cap of $0.016 billion, indicating a price to book ratio of 0.811 and a price to sales ratio of 0.94.

In the last 12-months Vivos Therapeutics Inc’s revenue was $0.017 billion with a gross profit of $0.013 billion and an EBITDA of $-0.022 billion. The EBITDA ratio measures Vivos Therapeutics Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vivos Therapeutics Inc’s operating margin was -135.5% while its return on assets stood at -55.5% with a return of equity of -127.3%.

In Q1, Vivos Therapeutics Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0.3%.

Vivos Therapeutics Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-1.019 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vivos Therapeutics Inc’s profitability.

Vivos Therapeutics Inc stock is trading at a EV to sales ratio of 0.0765 and a EV to EBITDA ratio of -0.0563. Its price to sales ratio in the trailing 12-months stood at 0.94.

Vivos Therapeutics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Vivos Therapeutics Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Vivos Therapeutics Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Vivos Therapeutics Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Vivos Therapeutics Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Vivos Therapeutics Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.69
52-Week High
$4.14
52-Week Low
$0.6
Analyst Target Price
$4.5

Vivos Therapeutics Inc stock is currently trading at $0.69 per share. It touched a 52-week high of $4.14 and a 52-week low of $4.14. Analysts tracking the stock have a 12-month average target price of $4.5.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Vivos Therapeutics Inc

The stock symbol (also called stock or share ticker) of Vivos Therapeutics Inc is VVOS

The IPO of Vivos Therapeutics Inc took place on 2020-12-11

Similar Industry Stocks (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Last Price
Chg
Chg%
$206.69
14.43
+7.51%
$283.59
-8.46
-2.9%
Pulmonx Corp (LUNG)
$13.64
0.41
+3.1%
$4.72
0.03
+0.64%
ResMed Inc (RMD)
$218
-2.87
-1.3%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered breathing, such as mild to moderate obstructive sleep apnea (OSA). The company is headquartered in Highlands Ranch, Colorado.

Address

9137 RIDGELINE BOULEVARD, SUITE 135, HIGHLANDS RANCH, CO, US